Search
Spotlight
In-person and virtual events just for HCPs
In-person and virtual events just for HCPs
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
Pipeline Report
OncClub
All Oncology News
Pipeline Report
Media
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Sponsored
Interactive Tools
Learning Modules
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
In-person and virtual events just for HCPs
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Optimizing Therapy for Patients with Advanced Renal Cell Carcinoma - Episode 7
Key Decision Factors in Selecting Frontline Therapy for Metastatic RCC
November 28, 2023
Ulka Vaishampayan, MD
,
Alan Tan, MD
,
Laurence Albiges, MD, PhD
,
Neeraj Agarwal, MD
,
Matthew T. Campbell, MD, MS
,
Benjamin Maughan, MD, PharmD
EP. 1: Overview on Advanced RCC: Epidemiology, Presentation, and Risk Stratification
EP. 2: Frontline Therapy for Advanced Renal Cell Carcinoma: Patient Scenario Discussion
EP. 3: Imaging and Staging Considerations in Renal Cell Carcinoma
EP. 4: Frontline Therapy for Renal Cell Carcinoma: Choosing the Right Regimen
EP. 5: Treatment Strategies for Non-Clear Cell Renal Cell Carcinoma
EP. 6: Comparing Treatment Combinations in Renal Cell Carcinoma
Now Viewing
EP. 7: Key Decision Factors in Selecting Frontline Therapy for Metastatic RCC
EP. 8: Sequencing and Second-Line Therapy in RCC: Patient Scenario
EP. 9: Managing AEs in Cabo Nivo Combination Therapy for Advanced RCC
EP. 10: Navigating Toxicity Discussions With Patients With Renal Cell Carcinoma
EP. 11: Novel Therapies for Advanced RCC: LITESPARK-005 and Treatment Sequencing
EP. 12: Triple Combination Therapies in RCC: Clinical Trial Insights
EP. 13: Key Takeaways: Advancements and Challenges in Kidney Cancer Treatment